Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients.
Zanichelli
A
A
Dipartimento di Scienze Cliniche L. Sacco, Università degli Studi di Milano, Ospedale Luigi Sacco, Milan, Italy.
Vacchini
R
R
Badini
M
M
Penna
V
V
Cicardi
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000728:Androgens / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D050718:Complement C1 Inhibitor Protein; D003625:Data Collection; D004341:Drug Evaluation; D005260:Female; D056829:Hereditary Angioedema Types I and II / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012008:Recurrence; D059039:Standard of Care; D014148:Tranexamic Acid / Q000627:therapeutic use; D017211:Treatment Failure
D000728:Androgens; D050718:Complement C1 Inhibitor Protein; D014148:Tranexamic Acid